5-7 November 2026
Hotel Mercure Budapest Castle Hill, Budapest, Hungary
Organizers: Kürşat Bozkurt (ECoP) and Imre Bihari (APh)
Hungarian Venous Forum
General information
Conference Venue
Mercure Budapest Castle Hill, Budapest, Krisztina krt. 41-43. 1013
Tel: 00-36-1-488 8100
Mercure Budapest Castle Hill| Comfortable Hotel in Budapest - ALL (accor.com)
Dates:
2-3 October 2026
2 October, Friday 9.00 – 17.30
3 October, Saturday 9.00 – 17.30
Registration Desk is open
2 October, Friday 7.30 – 18.00
3 October, Saturday 8.30 – 18.00
On Site Registration is available.
Congress Dinner
Hungarian Evening: Friday, 2 October, 19.00 - 22.00
Not included in the registration fee.
Congress Language
The official language of the conference is English.
Liability and Insurance
Neither the Organisers nor the Conference Secretariat will assume any responsibility whatsoever for damage or injury to persons or property during the Conference.
Participants are recommended to arrange their personal travel and health insurance.
Changes
The Organisers reserve the right to adjust or change the programme as necessary.
Abstract Submission Instructions
Dear colleague you are encouraged to submit an abstract of original research paper for oral or poster presentation. If you deal with venous diseases, have personal observations, innovations, studies, experience, or special cases then the 5th Another Phlebology workshop has been arranged just for you.
We prefer works which are original and were not presented at any other meetings or not widely accepted.
We require abstracts for all presentations including invited speakers and symposium programs.
There is no limit on the number of abstracts an individual may submit.
We ask the following structure of the abstract:
- Background
- Methods
- Results
- Conclusions
The text body should be between 400 and 500 words
This can contain tables, figures and references.
Every abstract will be published in English in the Hungarian Journal of Vascular Diseases.
All presentations are included in the evaluation of the Another Phlebology Award (500 Euro), regardless of the age and degree of the author(s). This will be handed over at the end of the meeting.
Please, send your abstract to the following email address: This email address is being protected from spambots. You need JavaScript enabled to view it.
Deadline: 1 June 2026
Another Phlebology Award 2026
All presentations are included in the evaluation of the Another Phlebology Award (500 Euro), regardless of the age and status of the author(s). This will be presented at the end of the meeting.
This award was first given at our 3rd meeting in 2019, and the winner was René Milleret (France) and at the 4th to Frantisek Zernovicky (Slovakia).
In the evaluation, how new the information is plays an important role. For a more precise judgement we are introducing what we call the Novelty Factor:
The Novelty Factor is a new evaluation possibility from one point of view, tries to assess how innovative the topic of the presentation is. Has it already been published in other conferences, or in a journal? Does it bring a change in everyday practice? Is it suitable for a colleague to try when they get home? Does the modification reported here cause a minor or major change in the diagnostic or therapeutic results? Or a new starting point for further research?
In the evaluation process, both the presenter and the audience will participate.
Preliminary Scientific Program
|
Thursday, 5 November |
|
|
10:30 - 12:30 |
ANOTHER PHLEBOLOGY SESSION – 1 Chair: Gloviczki P (USA), Zernovicky F (Slovakia), Bihari I (Hungary) Presentation 4 min, discussion 1 min
effective strategies beyond the textbooks 2. Bihari I (Hungary): What Flow is Within the Solidified Glue? 3. Akesson ML (Sweden): Solutio Catheter for Treatment and Tumescent Anaesthesia 4. Szolnoky Gy (Hungary): Measurement of Cell-mediated Immunity in Persons with and without Venous Leg Ulcers Using Tuberculin Skin Test 5. Phelan N (Ireland): Comparative Pre-Clinical Histopathological Evaluation of Acute Vein Wall Response Following Mechanical-Only Treatment with the ClariVein and InVera Infusion Devices 6. Slavin DA (Russia): Laser Crossectomy in EVLA: from the Anatomical Perfectionism of the Flush Technique to Simultaneous AASV Obliteration 7. Flor A (Austria): Effectiveness And Safety Of The Slim Vs. Swift Fiber In Combination With a Smart Pullback Device 8. Karniyevich S (Belorus): Vacuum-Assisted Endovenous Laser Ablation for Saphenous Veins >15 mm: Rationale and Design of a Multicentre Randomised Comparative Study 9. Üzeyir Yılmaz, Muhammet Turhan (Türkiye): Radiofrequency Ablation Versus Stripping in Great Saphenous Veins 10–15 mm in Diameter: A Two-Year Comparative Study 10. Simka M (Poland): Hybrid Chemical Ablation For The Treatment Of Large Varicose Veins Using The Cyanoacrylate Glue And Foam Sclerotherapy 11. Sipka B (Hungary): Differences in Tributary and Perforator Vein Management Among Hungarian and International Venous Specialists 12. Parikov M.A. (Russia): 10-Year Experience with Endovenous Laser Obliteration for the Elimination of Unwanted Veins of the Upper Extremities 13. Pozniakova O (Belarus): Technique and Results of the CLACS Procedure for the Treatment of Unaesthetic Veins 14. Bouayed NM (Algeria): How to manage recurrent varicose veins? 15. Riabinska O (Ukraine): Persistent Sciatic Vein: Variability of Anatomy and Clinical Manifestations. 16. Hoxha S, (Albania): From Amputation Threat to Limb Salvage: Percutaneous Venous Intervention in Advanced Chronic Venous Insufficiency with Non-Healing Ulceration — The Shkelqim Protocol 17. Bakhishev TE (Russia): Choice Of Treatment Strategy For Patients With Anterior Nutcracker Syndrome Using Da Vinci Robot-Assisted Surgery 18. Albana Kenga (Albenia): Successful Endovenous Laser Ablation in a Renal Transplant Recipient with Chronic Immunosuppression, Prior Femoral Deep Vein Thrombosis, and Thrombocytopenia: A Challenging Case Report 19. Umarov, FR (Uzbekistan): Ultrasound-Guided Cyanoacrylate Ablation of Incompetent Perforator Veins: Technical Feasibility and Safety in Recurrent Varicose Veins 20. Sipka B (Hungary): The First Practical Role of Ai in a Venous Practice: Patient Education and Digital Navigation 21. Okic A (Bosnia-Herzegovina): Biohumoral answer after sclerotharapy 22. Zakeryaev AB (Russia): Innovative Hybrid Treatment For May-Thurner Syndrome: Robotic Decompression With Balloon Angioplasty 23. Shushanik Simonyan (Russia): Varicose veins of the vulva: always separate or in combination with varicose veins of the lower extremities?" 24. Zsolt Pécsvárady (Hungary): Invasive treatment of a serious proximal deep vein thrombosis |
|
12:30 - 13:15 |
LUNCH |
|
13:15 - 13:30 |
OPENING |
|
13:15 - 13:20 |
Opening Speech A. Kürşat Bozkurt |
|
13:20 - 13:30 |
What is Another Phlebology? Imre Bihari |
|
13:30 - 15:30 |
COMPRESSION ANNO 2026 Chairs: Giovanni Mosti, Tobias Hirsch |
|
13:30 - 13:40 |
Compression to Treat Superficial Venous Disease Alun Davies |
|
13:40 - 13:48 |
Compression in the Management of Deep Venous Disease Giovanni Mosti |
|
13:48 - 13:56 |
Compression in the Management of Lymphoedema Tanja Planinsek Rucigaj |
|
13:56 - 14:04 |
How to Deal with Work Place Oedema? Tobias Hirsch |
|
14:04 - 14:12 |
Compression Adherence and Patient Self Motivation in Teatment |
|
14:12 - 14:20 |
Compression after SVI Interventions Igor Zolotukhin |
|
14:20 - 14:24 |
Selected Abstract - 1 |
|
14:24 - 14:36 |
INDUSTRY SPONSORED SESSION |
|
14:36 - 14:48 |
INDUSTRY SPONSORED SESSION |
|
14:48 - 15:00 |
INDUSTRY SPONSORED SESSION |
|
15:00 - 15:30 |
PANEL DISCUSSION |
|
15:30 - 16:00 |
COFFEE BREAK |
|
16:00 - 16:18 |
KEYNOTE LECTURE Speaker: Peter Gloviczki |
|
16:18 - 17:30 |
GUIDELINE UPDATE Chairs: Anil Hingorani, A. Kürşat Bozkurt |
|
16:18 - 16:26 |
Updated on AVF Leg Ulcer Guidelines Monica Gloviczki |
|
16:26 - 16:34 |
ESVS Guidelines on Superficial Venous Disease Marie Jose Van Rijn |
|
16:34 - 16:42 |
Gudelines on SVT/VTE Manj Gohel |
|
16:42 - 16:50 |
Pitfalls in Gudelines! Why We Need to Do Better with Quality and Implementation? Dan Carradice |
|
16:50 - 16:54 |
Selected Abstract – 2 Cardiovascular disease in chronic venous disease: a systematic review and meta-analysis. Joseph Nicholson, Balraj S Maan, Konstantinos K, Rachel Low, Sarah Onida, Alun H. Davies |
|
16:54 - 17:06 |
INDUSTRY SPONSORED SESSION |
|
17:06 - 17:18 |
INDUSTRY SPONSORED SESSION |
|
17:18 - 17:30 |
PANEL DISCUSSION |
|
17:30 – 19:30 |
Welcome Coctail + Concert |
|
Friday, 6 November |
|
|
08:00 - 10:00 |
PELVIC VENOUS DISEASE Chairs: Marald Wikkeling, Mark Whiteley |
|
08:00 - 08:08 |
SVP Classification Unraveled Marald Wikkeling |
|
08:08 - 08:13 |
DEBATE: Should A Diagnosed MTS Treated First in PeVD Cees Wittens |
|
08:13 - 08:18 |
DEBATE: Should A Diagnosed MTS Treated First in PeVD Mark Whiteley |
|
08:18 - 08:26 |
Treatment of Male PVD Serkan Ketenciler |
|
08:26 - 08:34 |
Differential Diagnosis of PEVD Marald Wikkeling |
|
08:34 - 08:42 |
Investigation of Patients with PEVD Carsten Arnoldussen |
|
08:42 - 08:50 |
Guidelines on PEVD - What is Emerging! Neil Khilnani |
|
08:50 - 08:54 |
Selected Abstract – 3
vein Isabel Manteca Björkman, Carlota Fernandez Prendes, Sara Bruce, Gustaf Tegler Sclerotherapy of Vulvar Varices in Pelvic Venous Disorder: Pudendal Nerve Decompression or Diagnostic Coincidence? I.M. Toonder |
|
08:54 - 09:06 |
INDUSTRY SPONSORED SESSION |
|
09:06 - 09:18 |
INDUSTRY SPONSORED SESSION |
|
09:18 - 09:35 |
PANEL DISCUSSION |
|
09:35 - 10:00 |
Eberhard Rabe Memorial Lecture Felicitas Pannier, Alun Davies, Cees Wittens |
|
10:00 - 10:30 |
COFFEE BREAK |
|
10:30 - 12:30 |
TREATMENT OF SUPERFICIAL VENOUS PATHOLOGY Chairs: Luca Palombi, Igor Suchkov |
|
10:30 - 10:35 |
DEBATE: Treating Competent Veins will Become the Norm to Reduce Recurrence Tobias Hirsch |
|
10:35 - 10:40 |
DEBATE: Treating Competent Veins will Become the Norm to Reduce Recurrence Peter Gloviczki |
|
10:40 - 10:48 |
EHIT and Its Brothers and Sisters Lowell Kabnick |
|
10:48 - 10:56 |
Experience of 2000 Perforator Vein Closure with Glue Imre Bihari |
|
10:56 - 11:04 |
Non-thermal Hifu Ablation of Varicose Veins by Cavitation: First Human Study Rene Milleret, Z. Galadja, O. Pichot |
|
11:04 - 11:12 |
Special Considerations When Treating the GSV and SSV Reflux Frank Zernovicky |
|
11:12 - 11:20 |
CVI and Neuropathy Nina Mzhavandze |
|
11:20 - 11:24 |
Selected Abstract – 4
results. Davies Bayesian meta-analysis. Gritskova Irina, Naumova Elena, Laberko Leonid |
|
11:24 - 11:36 |
INDUSTRY SPONSORED SESSION |
|
11:36 - 11:48 |
INDUSTRY SPONSORED SESSION |
|
11:48 - 12:00 |
INDUSTRY SPONSORED SESSION |
|
12:00 - 12:30 |
PANEL DISCUSSION |
|
12:30 - 13:30 |
LUNCH |
|
13:30 - 15:30 |
AMERICAN VENOUS FORUM SESSION Chairs: Kathleen Ozsvath, Rashad Bıshara |
|
13:30 - 13:35 |
DEBATE: Duplex Examination Alone is Sufficient to Determine SVI Intervention Suat Doğancı |
|
13:35 - 13:40 |
DEBATE: Duplex Examination Alone is Sufficient to Determine SVI Intervention Alun Davies, Marwah Salim |
|
13:40 - 13:48 |
Treating SVI in the Presence of Deep Venous Disease Kathleen Ozsvath |
|
13:48 - 13:56 |
Total Venous Ablation: Benefits & Pitfalls Luca Palombi |
|
13:56 - 14:04 |
Spectrum Study: What have We Learnt and What Should We have Done Differently? Kathy Gibson |
|
14:04 - 14:12 |
What are the Current Research Questions That need Answering in the Management of SVI? Sarah Onida |
|
14:12 - 14:20 |
Phlebectomy vs Foam Which is Best and Why? Tomasz Urbanek |
|
14:20 - 14:24 |
Selected Abstract - 5 |
|
14:24 - 14:48 |
INDUSTRY SPONSORED SESSION |
|
14:48 - 15:00 |
INDUSTRY SPONSORED SESSION |
|
15:00 - 15:30 |
PANEL DISCUSSION |
|
15:30 - 16:00 |
COFFEE BREAK |
|
16:00 - 18:00 |
TREATMENT OF DEEP VENOUS PATHOLOGY Chairs: Michal Stanisic, Selim Aydın |
|
16:00 - 16:10 |
Strategies in the Management of Venous Malformations Chung Lim |
|
16:10 - 16:18 |
Inflow Assesment for Deep Venous Stenting Marie Jose Van Rijn |
|
16:18 - 16:26 |
Mechanics of Stent Failure and How to Prevent Poor Outcomes? Manj Gohel |
|
16:26 - 16:34 |
Managing Venous Stent Occlusion - Options, Risk, and Results Suat Doğancı |
|
16:34 - 16:42 |
TBA |
|
16:42 - 16:50 |
Edited Case - Iliac Vein Recanalisation Michal Stanisic |
|
16:50 - 16:54 |
Selected Abstract – 6
Cyanoacrylate Closure for Great Saphenous Vein Insufficiency |
|
16:54 - 17:06 |
INDUSTRY SPONSORED SESSION |
|
17:06 - 17:18 |
INDUSTRY SPONSORED SESSION |
|
17:18 - 17:30 |
INDUSTRY SPONSORED SESSION |
|
17:30 - 18:00 |
PANEL DISCUSSION |
|
19:00 – 22:00 |
Networking Dinner |
|
Saturday, 8 November |
|
|
08:00 - 10:00 |
VEIN & LYMPHATIC UNIVERSITY SESSION Chairs: Lowell Kabnick, Victor Canata, Anil Hingorani, A. Kürşat Bozkurt |
|
08:00 - 08:05 |
DEBATE Lowell Kabnick |
|
08:05 - 08:10 |
DEBATE Choice! Victor Canata |
|
08:10 - 08:18 |
Role of Ultrasound in Cosmetic Phlebology Anil Hingorani |
|
08:18 - 08:26 |
Sousage Technique Victor Canata |
|
08:26 - 08:34 |
When and How We Should Treat Hand Veins? Alexander Flor |
|
08:34 - 08:42 |
Laser in the Management of Venous Flares |
|
08:42 - 08:50 |
Esthetic Complications after Aclerotherapy Eva Szabo |
|
08:50 - 08:54 |
Selected Abstract – 7
Mattings After Microsclerotherapy of Reticular Veins and Telangiectasia |
|
08:54 - 09:06 |
INDUSTRY SPONSORED SESSION |
|
09:06 - 09:18 |
INDUSTRY SPONSORED SESSION |
|
09:18 - 09:30 |
INDUSTRY SPONSORED SESSION |
|
09:30 - 10:00 |
PANEL DISCUSSION |
|
10:00 - 10:30 |
COFFEE BREAK |
|
10:30 - 12:30 |
TREATMENT OF VENOUS THROMBOEMBOLISM Chairs: Kathleen Ozsvath, Tanzer Çalkavur |
|
10:30 - 10:35 |
DEBATE: Preventing is Preventable: VTE Phrohylaxis Should Follow Endovenous Ablation Alun Davies |
|
10:35 - 10:40 |
DEBATE: Preventing is Preventable: VTE Phrohylaxis Should Follow Endovenous Ablation Lowell Kabnick |
|
10:40 - 10:48 |
Current Treatment of Superficial Vein Thrombosis Kathleen Ozsvath |
|
10:48 - 10:56 |
Optimal Imaging to Evaluate Acute DVT to Determine Treatment Options Carsten Arnoldussen |
|
10:56 - 11:04 |
Technical Strategies for Early Thrombus Removal in Acute Ilofemoral DVT Michal Stanisic |
|
11:04 - 11:12 |
Reasons for Early Re-occlusion after Venous Thrombectomy Kathleen Gibson |
|
11:12 - 11:20 |
New Generation Thrombectomy Devices Selim Aydın |
|
11:20 - 11:36 |
Selected Abstract – 8
inpatients: a systematic review Thromboembolism Prophylaxis in Major Trauma An AGREE II Study Systematic Review of Limb Salvage and Mortality Outcomes |
|
11:36 - 11:48 |
INDUSTRY SPONSORED SESSION |
|
11:48 - 12:00 |
INDUSTRY SPONSORED SESSION |
|
12:00 - 12:30 |
PANEL DISCUSSION |
|
12:30 - 13:30 |
LUNCH |
|
13:30 - 15:30 |
VENOUS ULCER CARE Chairs: Gabor Menyhei, Vugar Fattah-Pur |
|
13:30 - 13:35 |
DEBATE: Duplex Surveillance of Patients with C5 Disease Should be the Norm? Manj Gohel, Sarah Onida |
|
13:35 - 13:40 |
DEBATE: Duplex Surveillance of Patients with C5 Disease Should be the Norm? Wijnand Van Gent |
|
13:40 - 13:48 |
Treatment of Lipedema Anno 2026 Dilek Erer |
|
13:48 - 13:56 |
Which Compression Devices Should We use for Patients with VLU? |
|
13:56 - 14:04 |
Subdermal Plexus Injections to Cure Venous Leg Ulcers Rashad Bıshara |
|
14:04 - 14:12 |
Deep Venous Stenting in VLU Cees Wittens or Update on the Venous Valve Project TBA |
|
14:12 - 14:20 |
What are the Key Research Questions to Answer in VLU Patients? Peter Gloviczki |
|
14:20 - 14:40 |
Selected Abstract - 9/12
Analysis. Matthew Tan patients with chronic venous disease Comorbid Patients Strelnikova Ekaterina |
|
14:40 - 15:30 |
PANEL DISCUSSION |
|
15:30 - 16:00 |
COFFEE BREAK |
|
16:00 - 17:30 |
ANOTHER PHLEBOLOGY SESSION - 2 Presentation 4 min, discussion 1 min 1. Szabo A (Hungary): High-intensity-Focused Ultrasound Venous Ablation – First Hungarian Results 2. Andozhskaya Y.S. (Russia): Changes In Microcirculation Parameters In The Treatment Of Venous Ulsers In Comorbid Patients 3. Chernukha LM (Ukraine): From Device-Driven Energy Delivery to Data-Driven Control: A Comparative Analysis of Modern Endovenous Thermal Ablation Techniques in Chronic Venous Disease 4. Flor A (Austria): Endovenous Ablation of Leg Veins: Should We be More or Less Radical? 5. Menyhei G (Hungary): International Variations in Varicose Vein Treatment: a Registry Based Study 6. Mahmud M (Bosnia-Herzegovina): Endovenous Laser Ablation Combined with Ultrasound-Guided Foam Sclerotherapy in Treatment And Prevention of Venous Leg Ulcers 7. Pozniakova O (Belarus): EVLA Protocols. Questions and Non-standard solutions 8. Rozsos I (Hungary): Venous Ulcer Treatment? Foam, What Else! 9. Björkman IM (Sweden): Radiation Exposure in Primary Deep Endovenous Interventions Involving the Iliac Vein 10. Akulova A.A (Russia): Staged Endovascular Revascularization of the Iliac Segment 11. Jaroslaw Kalemba (Poland): Occurrence of Pain Following Endovenous Laser Ablation of Lower Limb Veins 12. Bihari I (Hungary): When is Liquid Better Than Foam? 13. Péter Boros (Hungary): Early and Mid-term Experiences with Flush Closure of Sapheno-Femoral Junction Treating Varicose Vein Disease 14. J Bowie (UK): Capillaroscopy Identifies Uniq ue Capillary Architecture Between Ceap Stages in Patients with Chronic Venous Disease 15. Marwah Salih (UK) The use of Thermal Imaging as a Diagnostic Tool in Superficial Venous Disease – Early Results. 16. Alekseev DN (Kyrgyzistan): Calculation of the Optimal LEED when Performing EVLA 17. Sasikaran M (UK): Artificial Intelligence Models for Venous Thromboembolism Risk Assessment in Adult Inpatients: a Systematic Review |
|
17:30 - 18:30 |
CLOSURE OF THE MEETING / AWARD CEREMONY / ADJOURN |